Chlorphenamine/codeine controlled release - Spriaso

Drug Profile

Chlorphenamine/codeine controlled release - Spriaso

Alternative Names: Chlorphenamine maleate/codeine phosphate extended release - Spriaso; Chlorpheniramine/codeine; Codeine/chlorpheniramine; LPCN 1084; Rinotuss12; Tuxarin ER

Latest Information Update: 08 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lipocine
  • Developer Spriaso
  • Class Antitussives; Morphinans; Opioid analgesics; Sedating antihistamines
  • Mechanism of Action Histamine H1 receptor antagonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Common cold; Cough

Most Recent Events

  • 08 Dec 2017 Chemical structure information added
  • 22 Jun 2015 Registered for Common cold in USA (PO)
  • 22 Jun 2015 Registered for Cough in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top